Profile data is unavailable for this security.
About the company
NextCell Pharma AB, formerly Cellaviva AB, is a Sweden-based biopharmaceutical company. The Company is focusing on research and development of stem cell therapies and is also running a tissue establishment and biobank, classified as healthcare provider. NextCell's business concept is to develop and commercialize mesenchymal stem cell products based on the Company's proprietary selection algorithm, primarily for the treatment of autoimmune diabetes, as well as other types of autoimmune diseases.
- Revenue in SEK (TTM)12.22m
- Net income in SEK-40.69m
- Incorporated2014
- Employees--
- LocationNextCell Pharma ABKarolinska Institutet Science ParkHalsovagen 7HUDDINGE 141 57SwedenSWE
- Phone+46 87355595
- Websitehttps://www.nextcellpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fluicell AB | 3.34m | -26.55m | 29.82m | 17.00 | -- | 25.01 | -- | 8.93 | -0.2286 | -0.2286 | 0.0296 | 0.0036 | 0.1624 | 0.6813 | 3.84 | 196,352.90 | -129.20 | -87.55 | -222.48 | -126.02 | 52.07 | 72.97 | -795.51 | -650.23 | 0.5001 | -- | -- | -- | 2.68 | 22.18 | -22.90 | -- | -- | -- |
| Klaria Pharma Holding AB (publ) | 7.15m | -34.17m | 32.48m | 5.00 | -- | 0.7897 | -- | 4.54 | -0.3347 | -0.3498 | 0.0709 | 0.3862 | 0.0739 | -- | 0.5426 | 1,429,400.00 | -35.34 | -37.27 | -58.14 | -51.56 | -- | -- | -478.10 | -2,077.34 | -- | -7.65 | -- | -- | -100.00 | -- | 71.17 | -- | -- | -- |
| Elicera Therapeutics AB | 11.23m | -16.40m | 32.99m | 2.00 | -- | 1.13 | -- | 2.94 | -0.8289 | -0.8289 | 0.5677 | 0.8291 | 0.2936 | -- | 8.13 | 5,615,030.00 | -42.88 | -40.06 | -66.66 | -49.74 | -- | -- | -146.02 | -415.41 | -- | -- | 0.00 | -- | 777.23 | -- | 15.64 | -- | -- | -- |
| Gabather AB | 0.00 | -9.44m | 35.47m | -- | -- | 59.24 | -- | -- | -0.652 | -0.652 | 0.00 | 0.0331 | 0.00 | -- | -- | -- | -133.71 | -56.57 | -480.99 | -67.36 | -- | -- | -- | -17,298,800.00 | -- | -- | -- | -- | -- | -- | -10.40 | -- | -- | -- |
| Modus Therapeutics Holding AB | 0.00 | -17.90m | 35.80m | 2.00 | -- | 2.02 | -- | -- | -1.04 | -1.04 | 0.00 | 0.492 | 0.00 | -- | -- | 0.00 | -114.31 | -141.06 | -237.09 | -278.44 | -- | -- | -- | -- | -- | -10.96 | 0.00 | -- | -- | -- | 2.31 | -- | -- | -- |
| Lipigon Pharmaceuticals AB | 16.41m | -12.13m | 41.34m | -- | -- | 1.45 | -- | 2.52 | -0.3229 | -0.3229 | 0.2543 | 0.225 | 0.7388 | -- | 14.81 | -- | -54.60 | -314.67 | -75.05 | -426.49 | -- | -- | -73.91 | -488.14 | -- | -- | -- | -- | -- | 444.44 | 67.83 | -- | -- | -- |
| NextCell Pharma AB | 12.22m | -40.69m | 44.87m | -- | -- | 0.6805 | -- | 3.67 | -1.18 | -1.18 | 0.3555 | 1.92 | 0.124 | 14.66 | 6.80 | -- | -41.28 | -34.92 | -45.63 | -37.06 | 6.61 | -68.21 | -332.90 | -538.60 | 4.97 | -- | 0.00 | -- | 80.96 | 72.85 | -15.21 | -- | -- | -- |
| Oncozenge AB | 0.00 | -15.90m | 45.56m | -- | -- | 2.44 | -- | -- | -1.36 | -1.36 | 0.00 | 1.59 | 0.00 | -- | -- | -- | -55.57 | -- | -60.45 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 65.91 | -- | -- | -- |
| Veg of Lund AB (publ) | 4.82m | -19.91m | 47.04m | 7.00 | -- | 1.12 | -- | 9.77 | -0.7328 | -0.7328 | 0.1519 | 1.01 | 0.1337 | 13.74 | 14.40 | 688,000.00 | -55.27 | -129.03 | -82.56 | -209.20 | -384.61 | -781.09 | -413.50 | -923.73 | 0.1256 | -12.90 | 0.1405 | -- | 89.57 | 39.87 | 56.02 | -- | -12.47 | -- |
| Pila Pharma AB | 1.46m | -9.93m | 51.16m | 1.00 | -- | 7.68 | -- | 34.97 | -0.5304 | -0.5304 | 0.0767 | 0.28 | 0.1513 | -- | 6.11 | 1,463,020.00 | -102.68 | -108.88 | -122.66 | -121.45 | -127.88 | -42.67 | -678.73 | -1,577.64 | -- | -159.47 | 0.104 | -- | -22.21 | -- | 62.92 | -- | -- | -- |
| Diagonal Bio AB | 23.00k | -11.68m | 54.03m | 4.00 | -- | 0.2468 | -- | 2,349.01 | -0.1982 | -0.1982 | 0.0004 | 0.3221 | 0.0007 | -- | 2.00 | 5,750.00 | -37.35 | -- | -44.49 | -- | -41,604.35 | -- | -50,769.57 | -- | 0.5105 | -104.20 | -- | -- | -88.67 | -- | 27.75 | -- | -- | -- |
| Coegin Pharma AB | 0.00 | -27.98m | 58.79m | -- | -- | 4.51 | -- | -- | -2.67 | -2.67 | 0.00 | 0.6404 | 0.00 | -- | -- | -- | -125.24 | -122.02 | -201.53 | -154.70 | -- | -- | -- | -- | -- | -170.65 | -- | -- | -- | -- | 20.60 | -- | -- | -- |
| Scandion Oncology A/S | 0.00 | -61.34m | 59.19m | 4.00 | -- | 1.22 | -- | -- | -1.52 | -1.52 | 0.00 | 1.20 | 0.00 | -- | -- | 0.00 | -63.25 | -45.09 | -76.67 | -52.65 | -- | -- | -- | -- | -- | -- | 0.0158 | -- | -- | -- | 48.89 | -- | -- | -- |
| PCI Biotech Holding ASA | 2.97m | -20.19m | 60.09m | 7.00 | -- | 1.55 | -- | 20.22 | -0.5443 | -0.5443 | 0.0801 | 1.05 | 0.0556 | -- | 0.6848 | -- | -37.78 | -36.44 | -41.97 | -40.14 | -- | -- | -679.43 | -1,055.43 | -- | -- | 0.0081 | -- | -37.05 | -20.78 | 63.13 | -- | -- | -- |
| Orphazyme A/S | 0.00 | -40.81m | 60.86m | 1.00 | -- | 2.73 | -- | -- | -737.75 | -737.75 | 0.00 | 403.34 | 0.00 | -- | -- | 0.00 | -68.42 | -76.08 | -94.18 | -105.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.00 | -- | -- | -- |
| Prolight Diagnostics AB (publ) | 0.00 | -27.75m | 61.47m | -- | -- | 0.1771 | -- | -- | -0.0984 | -0.0984 | 0.00 | 0.6946 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -13.84 | -- |
Data as of Apr 26 2024. Currency figures normalised to NextCell Pharma AB's reporting currency: Swedish Krona SEK
